Increased expression of urokinase‐type plasminogen activator receptor in the frontal cortex of patients with intractable frontal lobe epilepsy

Urokinase‐type plasminogen activator receptor (uPAR) is a glycosyl phosphatidylinositol‐anchored protein involved in cell adhesion, proliferation, differentiation, migration, invasion, and tissue repair and remodeling. Our aim was to investigate uPAR expression in the frontal cortex of patients with intractable frontal lobe epilepsy and to explore the possible role of uPAR in intractable epilepsy. Tissue samples were obtained from the frontal cortex of 25 patients who had undergone surgery for intractable epilepsy and 15 histologically normal frontal cortex tissues from patients with orbital frontal lobe severe contusion (the control group). The frontal cortex expression of uPAR was studied by Western blot and immnohistochemistry. Double immunofluorescence was used to determine the expression of uPAR in astrocytes, microglia, and neurons. The normal frontal cortex uPAR protein level was shown to be low. In the brain tissue of patients with intractable epilepsy, the expression of uPAR protein increased dramatically. Based on the results of double immunofluorescence, many uPAR‐positive cells are colocalized with the cell soma of NeuN‐positive neurons, whereas only a few GFAP‐ and CD11b‐positive cells colocalized with uPAR staining. These findings provide new information pertaining to the epileptogenesis of intractable epilepsy and suggest that increased expression of uPAR in human brain may be associated with human intractable epilepsy. © 2010 Wiley‐Liss, Inc.

[1]  A. Pitkänen,et al.  Expression of urokinase-type plasminogen activator receptor is increased during epileptogenesis in the rat hippocampus , 2009, Neuroscience.

[2]  Asla Pitkänen,et al.  Molecular and cellular basis of epileptogenesis in symptomatic epilepsy , 2009, Epilepsy & Behavior.

[3]  R. Vincentelli,et al.  Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. , 2008, Human molecular genetics.

[4]  Aamir Ahmad,et al.  Evolving role of uPA/uPAR system in human cancers. , 2008, Cancer treatment reviews.

[5]  N. Nagai,et al.  Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke , 2008, Neuroscience Letters.

[6]  M. Duffy,et al.  Cancer invasion and metastasis: changing views , 2008, The Journal of pathology.

[7]  H. Allgayer,et al.  The urokinase-system--role of cell proliferation and apoptosis. , 2008, Histology and histopathology.

[8]  S. Lorenzl,et al.  A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis , 2007, Experimental Neurology.

[9]  Pat Levitt,et al.  Disruption of Interneuron Development , 2005, Epilepsia.

[10]  P. Levitt,et al.  Region‐ and age‐specific deficits in γ‐aminobutyric acidergic neuron development in the telencephalon of the uPAR–/– mouse , 2005, The Journal of comparative neurology.

[11]  M. Cuzner,et al.  A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis. , 2005, The American journal of pathology.

[12]  L. Lund,et al.  Plasminogen activation and cancer , 2005, Thrombosis and Haemostasis.

[13]  Hennric Jokeit,et al.  Neuropsychological aspects of type of epilepsy and etiological factors in adults , 2004, Epilepsy & Behavior.

[14]  E. Tremoli,et al.  Endogenous proteolytic activity in a rat model of spontaneous cerebral stroke , 2003, Brain Research.

[15]  Caleb F. Davis,et al.  Genetic Disruption of Cortical Interneuron Development Causes Region- and GABA Cell Type-Specific Deficits, Epilepsy, and Behavioral Dysfunction , 2003, The Journal of Neuroscience.

[16]  A. Pitkänen,et al.  cDNA profiling of epileptogenesis in the rat brain , 2003, The European journal of neuroscience.

[17]  P. Carmeliet,et al.  uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.

[18]  S. Estus,et al.  Urokinase‐type plasminogen activator inhibits amyloid‐β neurotoxicity and fibrillogenesis via plasminogen , 2002, Journal of neuroscience research.

[19]  E. Lo,et al.  Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases , 2002, Journal of neuroscience research.

[20]  T. Luther,et al.  Cortical neurons of Creutzfeldt–Jakob disease patients express the urokinase-type plasminogen activator receptor , 2002, Neuroscience Letters.

[21]  A. Vaheri,et al.  Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. , 2001, The American journal of pathology.

[22]  J. Newcombe,et al.  Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage. , 2001, Brain : a journal of neurology.

[23]  J. Koziol,et al.  Rapid Differential Endogenous Plasminogen Activator Expression After Acute Middle Cerebral Artery Occlusion , 2001, Stroke.

[24]  J. Schwab,et al.  Lesion‐associated accumulation of uPAR/CD87‐ expressing infiltrating granulocytes, activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans , 2000, Neuropathology and applied neurobiology.

[25]  S. Scheff,et al.  The Plasmin System Is Induced by and Degrades Amyloid-β Aggregates , 2000, The Journal of Neuroscience.

[26]  S. Yoshimura,et al.  Elevation of mRNA levels of tissue-type plasminogen activator and urokinase-type plasminogen activator in hippocampus and cerebral cortex following middle cerebral artery occlusion in rats , 2000, Neurological research.

[27]  Y. Nagamine,et al.  The plasminogen activator system: biology and regulation , 1999, Cellular and Molecular Life Sciences CMLS.

[28]  M. R. Bigio,et al.  Localization of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse forebrain during postnatal development , 1999, International Journal of Developmental Neuroscience.

[29]  M. Chopp,et al.  The effect of age on expression of endogenous plasminogen activators after focal cerebral ischemia in mice , 1999, Brain Research.

[30]  Gary A. Rosenberg,et al.  Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  W. Doe,et al.  Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family. , 1995, European journal of biochemistry.

[32]  Y. Dudai,et al.  Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. A. Dent,et al.  Urokinase‐type Plasminogen Activator Expression by Neurons and Oligodendrocytes During Process Outgrowth in Developing Rat Brain , 1993, The European journal of neuroscience.

[34]  D. Owen,et al.  The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. , 1992, Development.

[35]  Josemir W Sander,et al.  National General Practice Study of Epilepsy (NGPSE) , 1992, Neurology.

[36]  H. Buettner,et al.  Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.